← Open Payments lookup

JUSTINA THOMAS: Open Payments

NPI 1487351748 · BEAUMONT, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$3,776 in 207 payments from 11 companies in 2025. Trend: 2023 $429 · 2024 $1,979 · 2025 $3,776

Food & beverage: $3,764Education: $12
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.34$627
Teva Pharmaceuticals USA, Inc.40$603
Neurocrine BioSciences, Inc.27$603
ABBVIE INC.31$519
Janssen Pharmaceuticals, Inc23$499
Vanda Pharmaceuticals Inc.17$272
E.R. Squibb & Sons, L.L.C.13$203
Lundbeck LLC10$196
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)6$131
Alkermes, Inc.5$105

Products named: REXULTI, INGREZZA, VRAYLAR, INVEGA SUSTENNA, AUSTEDO XR, UZEDY, COBENFY, FANAPT.

Industry payments across CA — which companies pay providers there.